다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Monopar Therapeutics Inc (MNPR)
Monopar Therapeutics Inc (MNPR) 뉴스

MNPR

Monopar Therapeutics (MNPR)

Monopar Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:MNPR

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/09/12	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/09/12	21:00	GlobeNewswire Inc.	Monopar Announces Positive Early Human Clinical Data Validating the Tumor Targeting Ability of MNPR-101-Zr	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/09/04	21:00	GlobeNewswire Inc.	Monopar to Participate in the H.C. Wainwright 26th Annual Global Investment Conference	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/08/28	05:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/08/28	05:05	GlobeNewswire Inc.	Monopar Regains Compliance with Nasdaq Minimum Bid Price Rule	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/08/21	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/08/21	21:00	GlobeNewswire Inc.	Monopar Receives Clearance to Proceed with Phase 1 Therapeutic Trial of Novel Radiopharmaceutical in Advanced Cancers	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/08/14	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/08/14	21:00	GlobeNewswire Inc.	Monopar Announces Initial Data for First Patient Dosed in Radiopharma Phase 1 Clinical Trial of MNPR-101-Zr	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/08/09	21:02	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/08/09	21:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/08/09	21:00	GlobeNewswire Inc.	Monopar Therapeutics Reports Second Quarter 2024 Financial Results and Recent Developments	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/08/09	21:00	GlobeNewswire Inc.	Monopar Therapeutics Announces 1-for-5 Reverse Stock Split	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/07/22	20:01	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/07/22	20:00	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/07/12	05:30	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/07/10	05:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/07/09	20:00	GlobeNewswire Inc.	Monopar Announces First Patient Enrolled in First-in-Human Phase 1 Trial for Its Novel Radiopharmaceutical MNPR-101-Zr	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/06/25	21:00	GlobeNewswire Inc.	Monopar Announces MNPR-101-RIT Abstract Accepted as a Top-Rated Oral Presentation at EANM’24	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/06/18	07:08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/06/11	20:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/06/11	20:30	GlobeNewswire Inc.	Monopar and NorthStar Amend & Extend Collaboration	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/06/10	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/06/10	21:00	GlobeNewswire Inc.	Monopar Presents Data Showcasing the Appeal of uPAR as a Radiopharma Cancer Target and of its lead Clinical Program at the 2024 SNMMI Annual Meeting	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/06/06	07:12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/06/01	05:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/05/31	07:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/05/25	05:59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/05/24	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MNPR	Monopar Therapeutics Inc
2024/05/24	21:00	GlobeNewswire Inc.	Monopar Announces CFO Succession	NASDAQ:MNPR	Monopar Therapeutics Inc

검색 관련기사 보기:NASDAQ:MNPR

1 2 3 4 5 6 7 8 9 10 다음 >>

BNP Paribas (QX)

US Dollar vs Euro

Deutsche Telekom (QX)

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관